ATE464055T1 - Topische zusammensetzungen mit phosphorylierten polyphenolen - Google Patents

Topische zusammensetzungen mit phosphorylierten polyphenolen

Info

Publication number
ATE464055T1
ATE464055T1 AT04761493T AT04761493T ATE464055T1 AT E464055 T1 ATE464055 T1 AT E464055T1 AT 04761493 T AT04761493 T AT 04761493T AT 04761493 T AT04761493 T AT 04761493T AT E464055 T1 ATE464055 T1 AT E464055T1
Authority
AT
Austria
Prior art keywords
phosphorylated
compositions containing
topical compositions
compositions
containing phosphorylated
Prior art date
Application number
AT04761493T
Other languages
English (en)
Inventor
Lieve Declercq
Hugo Corstjens
Daniel Maes
Brussel Willy Van
Geert Schelkens
Original Assignee
Ajinomoto Omnichem S A
Estee Lauder Coordination Ct N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Omnichem S A, Estee Lauder Coordination Ct N filed Critical Ajinomoto Omnichem S A
Application granted granted Critical
Publication of ATE464055T1 publication Critical patent/ATE464055T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04761493T 2004-09-14 2004-09-14 Topische zusammensetzungen mit phosphorylierten polyphenolen ATE464055T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BE2004/000132 WO2006029484A1 (en) 2004-09-14 2004-09-14 Topical compositions containing phosphorylated polyphenols

Publications (1)

Publication Number Publication Date
ATE464055T1 true ATE464055T1 (de) 2010-04-15

Family

ID=34958945

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04761493T ATE464055T1 (de) 2004-09-14 2004-09-14 Topische zusammensetzungen mit phosphorylierten polyphenolen

Country Status (12)

Country Link
US (2) US20080095866A1 (de)
EP (1) EP1799228B1 (de)
JP (1) JP2008513378A (de)
KR (1) KR101162251B1 (de)
CN (1) CN101018554B (de)
AT (1) ATE464055T1 (de)
AU (1) AU2004323347B2 (de)
CA (1) CA2579784C (de)
DE (1) DE602004026647D1 (de)
ES (1) ES2344142T3 (de)
MX (1) MX2007003126A (de)
WO (1) WO2006029484A1 (de)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070149618A1 (en) 2004-02-17 2007-06-28 Action Medicines, S.L. Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
US20080125485A1 (en) 2004-02-17 2008-05-29 Action Medicines Use of 2,5-Dihydroxybenzene Derivatives for Treating Actinic Keratosis
ES2238924B1 (es) 2004-02-17 2006-12-01 Investread Europa, S.L. Uso del acido 2,5-dihidroxibencenosulfonico, en la fabricacion de medicamentos de aplicacion en el tratamiento de enfermedades angiodependientes.
FR2892635B1 (fr) * 2005-10-28 2012-11-09 Engelhard Lyon Substance pour restaurer une co-expression et une interaction normales entre les proteines lox et nrage
DE102006017879A1 (de) * 2006-04-13 2007-10-25 Merck Patent Gmbh Verwendung von Flavonoiden
US8541467B2 (en) 2006-08-16 2013-09-24 Action Medicines, S.L. Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ
PT2056815E (pt) 2006-08-16 2013-04-03 Amderma Pharmaceuticals Llc Utilização de derivados de 2,5-dihidroxibenzeno para tratar dermatite
FR2917749B1 (fr) * 2007-06-19 2012-10-12 Laffort Utilisation de tanins en oenologie
US8344024B2 (en) 2007-07-31 2013-01-01 Elc Management Llc Anhydrous cosmetic compositions containing resveratrol derivatives
US9295621B2 (en) * 2007-07-31 2016-03-29 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant
US8080583B2 (en) 2007-07-31 2011-12-20 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone
JP2011500512A (ja) * 2007-07-31 2011-01-06 リメリック バイオファーマ，インコーポレイティド リン酸化ピロン類似体および方法
US20090035240A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent
WO2009018350A1 (en) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Pyrone analog compositions and methods
US20090035236A1 (en) 2007-07-31 2009-02-05 Maes Daniel H Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent
WO2009017866A1 (en) 2007-07-31 2009-02-05 Elc Management Llc Cosmetic compositions containing resveratrol derivatives
US8193155B2 (en) 2009-02-09 2012-06-05 Elc Management, Llc Method and compositions for treating skin
US8703161B2 (en) 2007-08-13 2014-04-22 Elc Management, Llc Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
US20090047309A1 (en) * 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
CN102617348B (zh) 2007-09-08 2016-05-18 Elc管理有限责任公司 阿魏酸白藜芦醇酯化合物、包含该化合物的组合物及其使用方法
US9185909B2 (en) * 2007-09-17 2015-11-17 The Trustees Of Columbia University In The City Of New York Synthesis of resveratrol-based natural products
DE102007052534A1 (de) * 2007-11-01 2009-05-07 Beiersdorf Ag Kosmetische Verwendung von weißem Teeextrakt zur Bräunung der Haut
US8734867B2 (en) 2007-12-28 2014-05-27 Liveleaf, Inc. Antibacterial having an extract of pomegranate combined with hydrogen peroxide
US20090263518A1 (en) 2008-04-17 2009-10-22 Barry Callebaut Ag Composition and Uses Thereof
KR101503924B1 (ko) * 2008-05-19 2015-03-18 주식회사 엘지생활건강 페루릭산을 함유하는 히알루론산 생성촉진제
EP2429481A4 (de) * 2008-06-25 2014-08-13 Elc Man Llc Verfahren und zusammensetzungen zur verbesserung des aussehens von haut und körper
CN101691384B (zh) * 2008-10-08 2012-09-26 深圳海王药业有限公司 含磷的二苯乙烯类化合物及其制备方法和用途
US8735620B2 (en) * 2008-12-17 2014-05-27 Epr Pharmaceuticals Pvt. Ltd Processes for preparing (E)-styrylbenzylsulfone compounds and uses thereof for treating proliferative disorders
WO2011028601A2 (en) 2009-08-26 2011-03-10 Mary Kay Inc. Topical skin care formulations comprising plant extracts
WO2011041487A1 (en) * 2009-09-30 2011-04-07 Innovotech, Llc Biocompatible and biodegradable polymers from renewable natural polyphenols
CN102985068B (zh) 2010-05-18 2014-10-22 荷兰联合利华有限公司 个人护理组合物
WO2011156311A2 (en) * 2010-06-07 2011-12-15 L'oreal Cosmetic compositions containing phenolic compounds
EP2640409A1 (de) * 2010-11-19 2013-09-25 Vitro-Bio Sarl Synergistische zusammensetzung von pflanzenextrakten zur behandlung von hauterkrankungen mit anomalem zellwachstum
CN102191183B (zh) * 2010-12-09 2014-03-19 徐凌川 金银花菌深层发酵生产工艺
US8728453B2 (en) 2011-02-28 2014-05-20 Innovotech, Llc Combinatorial polymeric compositions for drug delivery
GB201105411D0 (en) * 2011-03-31 2011-05-11 Univ Manchester Tight junctions modulators
WO2013049364A1 (en) * 2011-09-27 2013-04-04 The Trustees Of Columbia University In The City Of New York Resveratrol-based compounds
CN102846862A (zh) * 2012-09-07 2013-01-02 叶志军 一种治疗血热型牛皮癣的酊剂药物
US10383815B2 (en) 2012-09-14 2019-08-20 Elc Management Llc Method and compositions for improving selective catabolysis in cells of keratin surfaces
US9018177B2 (en) 2012-10-12 2015-04-28 L'oreal S.A. Cosmetic compositions for increasing bioavailability of the active compounds baicalin and/or vitamin C
US9072919B2 (en) 2012-10-12 2015-07-07 L'oreal S.A. Synergistic antioxidant cosmetic compositions containing at least one of baicalin and taxifolin, at least one of caffeine and nicotinamide, at least one of vitamin C and resveratrol and ferulic acid
EP2906547B2 (de) 2012-10-12 2022-10-26 L'Oréal Kosmetische zusammensetzungen mit mindestens einem hydrotrop und mindestens einem wirkstoff
US9023826B2 (en) 2012-10-12 2015-05-05 L'oreal S.A. Compositions containing adenosine and the hydrotropes caffeine and nicotinamide for cosmetic use
US9107853B2 (en) 2012-10-12 2015-08-18 L'oreal S.A. Compositions containing phenolic compounds and hydrotropes for cosmetic use
US8716351B1 (en) 2012-12-23 2014-05-06 Liveleaf, Inc. Methods of treating gastrointestinal spasms
KR101528135B1 (ko) * 2013-06-07 2015-06-12 충북대학교 산학협력단 백장미 추출물 또는 이로부터 분리된 피로갈롤 화합물을 유효성분으로 포함하는 아토피성 피부염 예방 또는 치료용 약제학적 조성물
US9669242B2 (en) 2013-07-01 2017-06-06 L'oreal Compositions containing at least two phenolic compounds, a lipid-soluble antioxidant and at least one hydrotrope for cosmetic use
CN103462987B (zh) * 2013-08-19 2015-11-18 江汉大学 表没食子儿茶素没食子酸酯硬脂酸酯的应用以及一种治疗银屑病的药物组合物
KR102105532B1 (ko) * 2013-10-17 2020-04-29 (주)아모레퍼시픽 만능 줄기세포의 유도 방법 및 상기 방법에 의해 제조된 만능줄기세포
KR102100270B1 (ko) * 2013-11-18 2020-04-14 주식회사 엘지생활건강 피부 재생, 주름 개선, 항염증 또는 피부 미백용 조성물
ES2786306T3 (es) 2014-02-06 2020-10-09 Biocogent Llc Composiciones y métodos mejorados que comprenden resveratrol
EA033620B1 (ru) * 2014-04-25 2019-11-11 Makhbuba Nabi Kyzy Velieva Лечебный состав для профилактики и лечения псориаза
WO2015176161A1 (en) 2014-05-23 2015-11-26 Triple Hair Inc. Compositions for reducing hair loss and/or increasing hair regrowth
WO2015178791A1 (ru) * 2014-05-23 2015-11-26 Артур Викторович МАРТЫНОВ Косметологическая и фармацевтическая композиция
US11696883B2 (en) 2014-05-23 2023-07-11 Triple Hair Inc. Compositions for reducing hair loss and/or increasing hair regrowth
WO2015183121A1 (ru) * 2014-05-26 2015-12-03 Общество с ограниченной ответственностью "Уникат" Устройство нагрева локальных участков трубопровода
CN105496996A (zh) * 2014-09-23 2016-04-20 四川九章生物科技有限公司 绿原酸在制备治疗银屑病的药物中的用途
US9957443B2 (en) 2015-02-05 2018-05-01 Purdue Research Foundation Phosphorylation of products for flame retardant applications
ES2902842T3 (es) 2015-07-08 2022-03-30 Triple Hair Inc Composición que comprende resveratrol y melatonina para reducir la caída y/o aumentar el crecimiento del cabello
KR101715294B1 (ko) * 2016-06-09 2017-03-10 연세대학교 산학협력단 디오스민 또는 이의 염을 유효성분으로 함유하는 피부보습 개선, 피부각질 제거, 피부탄력 증진, 홍반 억제, 피부주름 개선 또는 피부광노화 개선 효과를 갖는 조성물
KR20180027157A (ko) * 2016-09-06 2018-03-14 주식회사 피코스텍 아멘토플라본을 포함하는 피지 과다분비 또는 지루성 습진의 억제 또는 개선용 조성물
WO2018185715A1 (en) * 2017-04-06 2018-10-11 Msn Laboratories Private Limited, R&D Center Improved process for the preparation of n6-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-5'-adenylic acid, monoanhydride with (dichloromethylene) bisphosphonic acid and its pharmaceutically acceptable salts
US10138423B1 (en) 2017-05-31 2018-11-27 International Business Machines Corporation Resveratrol-based flame retardant materials
CN107320395B (zh) * 2017-08-14 2020-08-11 上海欧润化妆品有限公司 一种眼影及其制备方法
KR102019819B1 (ko) * 2017-11-15 2019-09-09 부산대학교 산학협력단 큐프레슈플라본 또는 아멘토플라본을 유효성분으로 함유하는 아토피성 피부염의 예방 또는 치료용 조성물
US12156791B2 (en) 2017-12-29 2024-12-03 Tricol Biomedical, Inc. Chitosan dressing for control of bleeding in transurethral prostatectomy
CN111787892B (zh) * 2017-12-29 2025-02-18 金珂生物医疗公司 抵抗溶解的组织粘附脱乙酰壳多糖材料
US11660236B2 (en) 2017-12-29 2023-05-30 Tricol Biomedical, Inc. Delivery systems for control of bleeding in transurethral prostatectomy
EP3777821A4 (de) * 2018-03-29 2022-03-09 LG Household & Health Care Ltd. Zusammensetzung zur linderung der hautbarrieredysfunktion
CN109112088A (zh) * 2018-08-31 2019-01-01 河南中医药大学 一种分解五倍子鞣质的混合菌株及其发酵百药煎的方法
CN109330992B (zh) * 2018-12-07 2021-04-09 中国医科大学 一种聚多巴胺修饰纳米结构脂质载体及其在皮内递药中的应用
CN109762021A (zh) * 2019-01-28 2019-05-17 安徽大学 一种脂溶性抗氧化剂及其制备方法
CN110003290B (zh) * 2019-04-22 2021-01-26 浙江工业大学 一种从菱角壳中制备可水解单宁类粗提物的机械化学提取方法
KR102014396B1 (ko) * 2019-06-05 2019-08-26 주식회사 엘지생활건강 피부 재생, 주름 개선, 항산화, 항염증 및 피부 미백용 조성물
FI130262B (en) * 2019-08-30 2023-05-17 Medicortex Finland Oy Formulations and compositions for use in the prevention or treatment of brain injury and neurodegenerative diseases
CN111138928A (zh) * 2020-01-10 2020-05-12 沈阳顺风新材料有限公司 一种高效抗菌环保涂料及其制备方法
KR102267195B1 (ko) * 2020-12-04 2021-06-22 (주) 신아비티 균주 배양액으로부터 분리된 활성 물질을 포함하는 피부 개선용 조성물
KR102751617B1 (ko) * 2021-11-22 2025-01-10 바이오스펙트럼 주식회사 이소클로로겐산 또는 이의 염을 유효성분으로 포함하는 피부 로사시아 예방 및 개선용 조성물
CN114158731B (zh) * 2021-12-10 2023-08-01 湖南德诺健康产业集团有限公司 一种富含多酚的膳食组合物及其在改善肥胖引起的精液品质降低方面的应用
US20250339361A1 (en) 2022-11-02 2025-11-06 Nutrition & Biosciences USA 4, Inc. Compositions comprising xanthan gum and crystalline alpha-1,3-glucan
WO2024105203A1 (en) 2022-11-17 2024-05-23 Vitexia Aps Novel anti-senescence compounds
WO2024258190A1 (ko) * 2023-06-16 2024-12-19 코스맥스 주식회사 새치 염모제 조성물 및 이의 제조 방법
WO2025053304A1 (ko) * 2023-09-07 2025-03-13 한국교통대학교산학협력단 색소를 포함하는 헤어 컬러 조성물 및 이를 포함하는 화장료 조성물
WO2025072417A1 (en) 2023-09-29 2025-04-03 Nutrition & Biosciences USA 4, Inc. Polysaccharide derivatives
WO2025072419A1 (en) 2023-09-29 2025-04-03 Nutrition & Biosciences Usa 1, Llc Crosslinked alpha-glucan derivatives
WO2025072416A1 (en) 2023-09-29 2025-04-03 Nutrition & Biosciences USA 4, Inc. Polysaccharide derivatives
CN117554550B (zh) * 2023-12-29 2024-06-04 大连博源医学科技有限公司 血浆中儿茶酚胺代谢物的液相色谱串联质谱检测方法和组合稳定剂
WO2025199079A1 (en) 2024-03-20 2025-09-25 Nutrition & Biosciences USA 4, Inc. Esterification of alpha-glucan comprising alpha-1,6 glycosidic linkages
WO2026024663A1 (en) 2024-07-24 2026-01-29 Nutrition & Biosciences USA 4, Inc. Compositions comprising alpha-glucan with alpha-1,3 glycosidic linkages
WO2026039397A1 (en) 2024-08-13 2026-02-19 Nutrition & Biosciences USA 4, Inc. Alpha-glucan graft copolymer derivatives
WO2026076090A1 (en) 2024-10-02 2026-04-09 Danisco Usa Inc. Beta-1,3-glucan compositions

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3206725A1 (de) * 1981-05-13 1982-12-02 Merck Patent Gmbh, 6100 Darmstadt Schwer loesliche salze von aminoglykosidantibiotika
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
DE3942688A1 (de) * 1989-12-22 1991-06-27 Henkel Kgaa Mund- und zahnpflegemittel
JPH07509442A (ja) * 1991-11-18 1995-10-19 メレルダウファーマスーティカルズ　インコーポレイテッド ウィルス病処置でのホスホリル化フラボノイド類
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
US5925621A (en) * 1995-10-13 1999-07-20 Rush-Presbyterian, St. Luke's Medical Center Method for preventing sexually transmitted diseases
JPH09194493A (ja) * 1996-01-11 1997-07-29 Ajinomoto Takara Corp:Kk タンニン組成物
US6270780B1 (en) * 1997-07-25 2001-08-07 Chesebrough-Pond's Usa Co., Division Of Conopco Cosmetic compositions containing resveratrol
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.
US6008260A (en) * 1998-01-09 1999-12-28 Pharmascience Cancer chemopreventative composition and method
US6414037B1 (en) 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
JP2002505447A (ja) 1998-02-25 2002-02-19 サイカラー インコーポレイテッド カプセルに封入した放射線感光性組成物を使用した画像形成システム
FR2777184B1 (fr) 1998-04-10 2001-08-24 Oreal Utilisation d'au moins un hydroxystilbene en tant qu'agent diminuant l'adhesion des micro-organismes
FR2777186B1 (fr) * 1998-04-10 2001-03-09 Oreal Utilisation d'au moins un hydroxystilbene dans une composition raffermissante
US6696495B2 (en) * 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
FR2787319B1 (fr) 1998-12-22 2002-06-14 Oreal Utilisation d'hydroxystilbenes pour la teinture, composition prete a l'emploi les contenant et procede de teinture
US6544581B1 (en) * 1999-06-22 2003-04-08 Canandaigua Wine Company, Inc. Process for extraction, purification and enrichment of polyphenolic substances from whole grapes, grape seeds and grape pomace
IT1318425B1 (it) * 2000-03-24 2003-08-25 D B P Dev Biotechnological Pro Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.
US6437004B1 (en) 2000-04-06 2002-08-20 Nicholas V. Perricone Treatment of skin damage using olive oil polyphenols
ITMI20010528A1 (it) * 2001-03-13 2002-09-13 Istituto Biochimico Pavese Pha Complessi di resveratrolo con fosfolipidi loro preparazione e composizioni farmaceutiche e cosmetiche
JP2002306126A (ja) * 2001-04-16 2002-10-22 Sanei Gen Ffi Inc タンニン含有組成物
WO2003086414A1 (en) * 2002-04-10 2003-10-23 Arizona Board Of Regents Structural modification of resveratrol: sodium resverastatin phosphate
US20050080024A1 (en) * 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives for the treatment of cardiovascular disorders
AU2003288019A1 (en) * 2002-12-18 2004-07-09 L'oreal Use of an alkyl ether of hydroxystilbene for the treatment of dry skin
WO2006029483A1 (en) 2004-09-14 2006-03-23 Ajinomoto Omnichem S.A. Phosphorylated polyphenols as colour-stable agents
WO2006078941A2 (en) 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Novel sirtuin activating compounds and methods of use thereof

Also Published As

Publication number Publication date
CN101018554A (zh) 2007-08-15
CA2579784A1 (en) 2006-03-23
MX2007003126A (es) 2007-08-02
US20090247490A1 (en) 2009-10-01
ES2344142T3 (es) 2010-08-19
DE602004026647D1 (de) 2010-05-27
CA2579784C (en) 2013-02-26
WO2006029484A1 (en) 2006-03-23
EP1799228A1 (de) 2007-06-27
KR101162251B1 (ko) 2012-07-04
US20080095866A1 (en) 2008-04-24
JP2008513378A (ja) 2008-05-01
AU2004323347A1 (en) 2006-03-23
EP1799228B1 (de) 2010-04-14
AU2004323347B2 (en) 2011-02-24
KR20070057831A (ko) 2007-06-07
US8465973B2 (en) 2013-06-18
CN101018554B (zh) 2010-10-27

Similar Documents

Publication Publication Date Title
ATE464055T1 (de) Topische zusammensetzungen mit phosphorylierten polyphenolen
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
EP2193785A3 (de) Extrakte von Tetraselmis sp. für kosmetische und therapeutische Zwecke
BRPI0410888A (pt) uso de derivados de difenilmetano como inibidores de tirosinase
BR112015007878A2 (pt) composto compreendendo oligonucleotídeo modificado, composição, combinação e uso dos mesmos
HK1198320A1 (zh) 含各種天然成分組合的皮膚護理組合物
MX2009005308A (es) Composiciones que comprenden peroxido de benzoilo, al menos un derivado del acido naftoico y al menos un compuesto del tipo polimeros de poliuretano o derivados de estos y sus usos.
YU4602A (sh) Farmaceutske formulacije zaštićene od dejstva mikroorganizama
WO2010085039A3 (ko) 노긴―유래 펩타이드 및 그의 용도
PH12013502215A1 (en) Beautiful-skin-promoting agent and use thereof
TW200744661A (en) Topical cosmetic formulations for regulating and improving the moisture content of the skin
WO2006087759A3 (en) Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field
WO2005000248A3 (en) Compositions and methods for skin conditioning
EA200701190A1 (ru) Композиция на основе растительных экстрактов ajuga reptans для предупреждения выпадения волос, стимулирования роста волос, регуляции продукции кожного сала
MX2014003449A (es) Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.
WO2010064878A3 (ko) 레온토포딕산을 유효성분으로 함유하는 주름개선용 피부 화장료 조성물
MXPA05014184A (es) Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral.
MX2010001693A (es) Composicion pulverizable que contiene extracto de hojas de parra rojas.
BRPI0512964A (pt) composições para cuidados pessoais com hipossensibilidade melhorada
PT1809383E (pt) Composições cosméticas
WO2007082864A3 (en) Use of chavicol as an antiseptic
MY170724A (en) Use of certain trioxygenated benzene derivatives in body fat management
DK1893237T3 (da) Farmaceutisk sammensætning, der omfatter en organopolysiloxan ela-stomer og et solubiliseret aktivt stof
SG161309A1 (en) Hair tonic
ES2187446T3 (es) Composicion para el tratamiento de la psoriasis.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties